These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26347134)

  • 1. Anticancer activities of self-assembled molecular bowls containing a phenanthrene-based donor and Ru(II) acceptors.
    Kim I; Song YH; Singh N; Jeong YJ; Kwon JE; Kim H; Cho YM; Kang SC; Chi KW
    Int J Nanomedicine; 2015; 10 Spec Iss(Spec Iss):143-53. PubMed ID: 26347134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls.
    Mishra A; Jeong YJ; Jo JH; Kang SC; Lah MS; Chi KW
    Chembiochem; 2014 Mar; 15(5):695-700. PubMed ID: 24677392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer potency and multidrug-resistant studies of self-assembled arene-ruthenium metallarectangles.
    Dubey A; Min JW; Koo HJ; Kim H; Cook TR; Kang SC; Stang PJ; Chi KW
    Chemistry; 2013 Aug; 19(35):11622-8. PubMed ID: 23852626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination-Driven Self-Assembly and Anticancer Potency Studies of Ruthenium-Cobalt-Based Heterometallic Rectangles.
    Singh N; Jang S; Jo JH; Kim DH; Park DW; Kim I; Kim H; Kang SC; Chi KW
    Chemistry; 2016 Nov; 22(45):16157-16164. PubMed ID: 27689935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination-Driven Self-Assembly Using Ditopic Pyridyl-Pyrazolyl Donor and p-Cymene Ru(II) Acceptors: [2]Catenane Synthesis and Anticancer Activities.
    Jo JH; Singh N; Kim D; Cho SM; Mishra A; Kim H; Kang SC; Chi KW
    Inorg Chem; 2017 Jul; 56(14):8430-8438. PubMed ID: 28665136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity of opened arene ruthenium metalla-assemblies.
    Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B
    Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages.
    Dubey A; Park DW; Kwon JE; Jeong YJ; Kim T; Kim I; Kang SC; Chi KW
    Int J Nanomedicine; 2015; 10 Spec Iss(Spec Iss):227-40. PubMed ID: 26366074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity of tetracationic arene ruthenium metalla-cycles.
    Barry NP; Edafe F; Therrien B
    Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water-soluble Ru(II)-anethole compounds with promising cytotoxicity toward the human gastric cancer cell line AGS.
    Carrillo E; Ramírez-Rivera S; Bernal G; Aquea G; Tessini C; Thomet FA
    Life Sci; 2019 Jan; 217():193-201. PubMed ID: 30528721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembly of Discrete Ru
    Ajibola Adeyemo A; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
    Inorg Chem; 2017 Jan; 56(1):608-617. PubMed ID: 27997153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity.
    Zhao Y; Zhang L; Li X; Shi Y; Ding R; Teng M; Zhang P; Cao C; Stang PJ
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4090-4098. PubMed ID: 30765514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordination-driven self-assembly of ruthenium(ii) architectures: synthesis, characterization and cytotoxicity studies.
    Adeyemo AA; Shettar A; Bhat IA; Kondaiah P; Mukherjee PS
    Dalton Trans; 2018 Jun; 47(25):8466-8475. PubMed ID: 29901668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled metalla-bowls for selective sensing of multi-carboxylate anions.
    Mishra A; Vajpayee V; Kim H; Lee MH; Jung H; Wang M; Stang PJ; Chi KW
    Dalton Trans; 2012 Jan; 41(4):1195-201. PubMed ID: 22116403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR spectroscopy and DFT calculations of a self-assembled arene ruthenium rectangle obtained from a combination of coordination and hydrogen bonds.
    Appavoo D; Raja N; Deschenaux R; Therrien B; Carnevale D
    Dalton Trans; 2016 Jan; 45(4):1410-21. PubMed ID: 26675884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of two novel ruthenium compounds in gastric cancer cells.
    Ramírez-Rivera S; Pizarro S; Gallardo M; Gajardo F; Delgadillo A; De La Fuente-Ortega E; MacDonnell FM; Bernal G
    Life Sci; 2018 Nov; 213():57-65. PubMed ID: 30326218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
    Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
    Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.